Secondary Central Nervous System Lymphoma (SCNSL)

Explore clinical trials studying Secondary Central Nervous System Lymphoma (SCNSL). Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Secondary Central Nervous System Lymphoma (SCNSL) trial results

Recruiting

NCT07082868

Conditions: Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma (PCNSL), +4 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States

Recruiting

NCT05131022

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: City of Hope Duarte, California, United States

University of California, San Francisco San Francisco, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Yale Cancer Center New Haven, Connecticut, United States

View all 62 locations

Recruiting

NCT07410520

Conditions: Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

Completed

NCT03703167

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States